You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 12, December 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Substance Abuse/ Alcoholism
 •Adolescent Medicine
 •Alert me on articles by topic

Dextromethorphan Abuse in Adolescence

An Increasing Trend: 1999-2004

Jodi K. Bryner, PharmD; Uerica K. Wang, PharmD; Jenny W. Hui, PharmD; Merilin Bedodo, PharmD; Conan MacDougall, PharmD; Ilene B. Anderson, PharmD

Arch Pediatr Adolesc Med. 2006;160:1217-1222.

Objectives  To analyze the trend of dextromethorphan abuse in California and to compare these findings with national trends.

Design  A 6-year retrospective review.

Setting  California Poison Control System (CPCS), American Association of Poison Control Centers (AAPCC), and Drug Abuse Warning Network (DAWN) databases from January 1, 1999, to December 31, 2004.

Participants  All dextromethorphan abuse cases reported to the CPCS, AAPCC, and DAWN. The main exposures of dextromethorphan abuse cases included date of exposure, age, acute vs long-term use, coingestants, product formulation, and clinical outcome.

Main Outcome Measure  The annual proportion of dextromethorphan abuse cases among all exposures reported to the CPCS, AAPCC, and DAWN databases.

Results  A total of 1382 CPCS cases were included in the study. A 10-fold increase in CPCS dextromethorphan abuse cases from 1999 (0.23 cases per 1000 calls) to 2004 (2.15 cases per 1000 calls) (odds ratio, 1.48; 95% confidence interval, 1.43-1.54) was identified. Of all CPCS dextromethorphan abuse cases, 74.5% were aged 9 to 17 years; the frequency of cases among this age group increased more than 15-fold during the study (from 0.11 to 1.68 cases per 1000 calls). Similar trends were seen in the AAPCC and DAWN databases. The highest frequency of dextromethorphan abuse occurred among adolescents aged 15 and 16 years. The most commonly abused product was Coricidin HBP Cough & Cold Tablets.

Conclusions  Our study revealed an increasing trend of dextromethorphan abuse cases reported to the CPCS that is paralleled nationally as reported to the AAPCC and DAWN. This increase was most evident in the adolescent population.


Author Affiliations: Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco (Drs Bryner, Wang, Hui, Bedodo, MacDougall, and Anderson), and San Francisco Division, California Poison Control System (Dr Anderson).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Honey, Dextromethorphan, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents
Paul et al.
Arch Pediatr Adolesc Med 2007;161:1140-1146.
ABSTRACT | FULL TEXT  

Sophia
Kaye and Wyatt
Emerg. Med. J. 2007;24:374-374.
FULL TEXT  

Increase in Dextromethorphan Abuse Among Adolescents
Paul
AAP Grand Rounds 2007;17:26-27.
FULL TEXT  

More adolescents abusing dextromethorphan
Kemp
AAP News 2007;28:2-2.
FULL TEXT  

Dextromethorphan Abuse Is on the Rise Nationwide
JWatch Emergency Med. 2007;2007:5-5.
FULL TEXT  

Dramatic Increase in Dextromethorphan Abuse Among Adolescents
JWatch General 2006;2006:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.